Related Experiment Video
Updated: Jul 6, 2025

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
Published on: August 25, 2017
[Eosinophilic chronic obstructive pulmonary disease: A review].
1Pirogov Russian National Research Medical University.
Chronic obstructive pulmonary disease (COPD) involves airway inflammation and remodeling. Eosinophilic COPD, a distinct subtype, may benefit from targeted therapies like monoclonal antibodies, improving prognosis.
Area of Science:
- Pulmonology
- Immunology
Background:
- Chronic obstructive pulmonary disease (COPD) is a significant global health issue characterized by airflow limitation and airway remodeling.
- A subset of COPD patients (20-40%) exhibits eosinophilic airway inflammation, similar to asthma, and this phenotype is linked to more severe airway remodeling.
Conclusions:
- Eosinophilic COPD represents a specific endotype with unique pathological features.
- Biomarkers like eosinophil counts are crucial for personalized treatment strategies in COPD.
- Targeted biologic therapies show promise for managing eosinophilic COPD, warranting further clinical investigation.
Related Concept Videos
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation

